South Korea Biopsy Devices Market Insight
Published: 16 June 2026 | Report Format: Electronic (PDF)
The South Korea biopsy devices market is expected to grow at a CAGR of around 7.1% owing to the rising prevalence of cancer, increasing demand for early disease diagnosis, advancements in minimally invasive biopsy procedures, expanding healthcare infrastructure, and growing adoption of image-guided diagnostic technologies.
South Korea Biopsy Devices Market Insight Forecasts to 2035
- The South Korea Biopsy Devices Market Size was Estimated at USD 185 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.1% from 2025 to 2035
- The South Korea Biopsy Devices Market Size is Expected to Reach USD 370 Million by 2035
Notable Insights for the South Korea Biopsy Devices Market
- • Based on the Segmentation by Product Type, it can be observed that the Core Needle Biopsy Devices segment is leading the South Korea Biopsy Devices Market in 2025, holding nearly 48% market share due to high diagnostic accuracy, minimally invasive procedures.
- Based on the Segmentation by Application, it can be seen that the Oncology Diagnostics segment accounted for approximately 64% market share in 2025, mainly driven by rising cancer incidence rates, increasing screening programs, and growing demand for precise tissue sampling.
- The global revenue of Becton, Dickinson and Company (BD) in fiscal year 2025 stood at nearly USD 21 billion, supported by strong demand for biopsy instruments, diagnostic solutions, interventional devices.
- Increasing investments in precision diagnostics, image-guided interventions, as advanced biopsy technologies improve diagnostic accuracy by nearly 38% while reducing procedure-related complications by approximately 25%.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
• Intelligent Market Research Based on AI for Medical Devices & Diagnostics
Decisions Advisors provides intelligent market research covering biopsy technologies, diagnostic imaging systems, oncology diagnostics, minimally invasive procedures, and pathology solutions. The research identifies growth opportunities, technology adoption trends, competitive positioning, and strategic developments shaping the South Korea Biopsy Devices Market.
• Highly Effective Research Approaches with Accurate Forecast Analysis
The research methodology incorporates primary interviews, healthcare industry analysis, medical device value-chain assessment, and data triangulation techniques to deliver accurate market sizing, growth forecasting, investment evaluation, and technology trend analysis. The study examines demand across hospitals, diagnostic centers, specialty clinics, and cancer treatment facilities.
• Highly Competitive Environment Analysis
The report provides comprehensive analysis of leading biopsy device manufacturers, product innovations, regulatory developments, strategic partnerships, acquisitions, and research initiatives. It also evaluates emerging diagnostic technologies, healthcare infrastructure expansion, and future growth opportunities within the South Korea Biopsy Devices Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Biopsy Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea South Korea Biopsy Devices Market
- Becton, Dickinson and Company (BD)
- Hologic, Inc.
- Danaher Corporation
- Boston Scientific Corporation
- Cook Medical
- Cardinal Health, Inc.
- Argon Medical Devices, Inc.
- Medtronic plc
- Fujifilm Holdings Corporation
- Olympus Corporation
Recent Developments:
- In September 2025, Hologic, Inc. introduced an advanced image-guided breast biopsy platform designed to improve tissue sampling accuracy and streamline clinical workflow in diagnostic centers.
- In May 2025, Olympus Corporation expanded its minimally invasive biopsy product portfolio with next-generation endoscopic biopsy solutions aimed at improving gastrointestinal cancer diagnosis.
Market Segmentation:
South Korea Biopsy Devices Market, By Product Type
- Core Needle Biopsy Devices
- Vacuum-Assisted Biopsy Devices
- Fine Needle Aspiration Biopsy Devices
- Image-Guided Biopsy Systems
- Biopsy Forceps & Accessories
South Korea Biopsy Devices Market, By Technology
- Ultrasound-Guided Biopsy
- MRI-Guided Biopsy
- CT-Guided Biopsy
- Stereotactic-Guided Biopsy
- Endoscopic Biopsy Techniques
South Korea Biopsy Devices Market, By Application
- Oncology Diagnostics
- Gastroenterology
- Gynecology
- Pulmonology
- Urology
Expert Views:
The South Korea Biopsy Devices Market is expected to witness sustained growth due to increasing cancer prevalence, rising awareness of early disease detection, and growing adoption of minimally invasive diagnostic procedures. Advances in image-guided biopsy technologies, precision medicine initiatives, and AI-supported pathology solutions will enhance diagnostic efficiency and clinical outcomes. Furthermore, expanding healthcare investments and strengthening oncology care infrastructure are anticipated to accelerate demand for advanced biopsy devices across hospitals, specialty clinics, and diagnostic centers through 2035.
Author: Komal and Radhika By Decisions Advisors and Consulting